Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.2 - $0.5 $12,102 - $30,257
-60,514 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$0.57 - $1.29 $3,844 - $8,701
-6,745 Reduced 10.03%
60,514 $35,000
Q2 2021

Aug 16, 2021

BUY
$1.46 - $2.25 $98,198 - $151,332
67,259 New
67,259 $114,000
Q2 2018

Aug 14, 2018

SELL
$1.44 - $2.24 $40,726 - $63,351
-28,282 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$2.22 - $2.79 $62,786 - $78,906
28,282
28,282 $72,000

About TREVENA INC


  • Ticker TRVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 173,680,992
  • Market Cap $273M
  • Description
  • Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...
More about TRVN
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.